z-logo
Premium
Poster ‐ 08: Preliminary Investigation into Collapsed‐Cone based Dose Calculations for COMS Eye Plaques
Author(s) -
Morrison Hali,
Me Geetha,
Sloboda Ron
Publication year - 2016
Publication title -
medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 180
eISSN - 2473-4209
pISSN - 0094-2405
DOI - 10.1118/1.4961782
Subject(s) - nuclear medicine , dosimetry , radiation treatment planning , materials science , biomedical engineering , medicine , radiology , radiation therapy
Purpose: To investigate the accuracy of model‐based dose calculations using a collapsed‐cone algorithm for COMS eye plaques loaded with I‐125 seeds. Methods: The Nucletron SelectSeed 130.002 I‐125 seed and the 12 mm COMS eye plaque were incorporated into a research version of the Oncentra® Brachy v4.5 treatment planning system which uses the Advanced Collapsed‐cone Engine (ACE) algorithm. Comparisons of TG‐43 and high‐accuracy ACE doses were performed for a single seed in a 30×30×30 cm 3 water box, as well as with one seed in the central slot of the 12 mm COMS eye plaque. The doses along the plaque central axis (CAX) were used to calculate the carrier correction factor, T(r), and were compared to tabulated and MCNP6 simulated doses for both the SelectSeed and IsoAid IAI‐125A seeds. Results: The ACE calculated dose for the single seed in water was on average within 0.62 ± 2.2% of the TG‐43 dose, with the largest differences occurring near the end‐welds. The ratio of ACE to TG‐43 calculated doses along the CAX (T(r)) of the 12 mm COMS plaque for the SelectSeed was on average within 3.0% of previously tabulated data, and within 2.9% of the MCNP6 simulated values. The IsoAid and SelectSeed T(r) values agreed within 0.3%. Conclusions: Initial comparisons show good agreement between ACE and MC doses for a single seed in a 12 mm COMS eye plaque; more complicated scenarios are being investigated to determine the accuracy of this calculation method.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here